To understand the workings of DNA in relation to disease, scientists at Los Alamos National Laboratory have developed the ...

Orange County’s third largest medical diagnostics and testing company is being acquired by a fast-growing Chicago-based firm ...

David H. Holman, Lestin L. Kenton Jr. and Kristina Caggiano Kelly of Sterne, Kessler, Goldstein & Fox PLLC discuss ...

To separate AI hype from reality in medicine, a doctor and author of a book on generative AI’s future in medicine suggests asking three simple questions.

The last decade has seen a swell of biotech startups using AI to design proteins. These are seven companies to watch.

Gene fusions are vital biomarkers for tumor diagnosis and drug development, with precise detection becoming increasingly ...

Researchers are warning that artificial intelligence tools gaining popularity in the fields of genetics and medicine can lead to flawed conclusions about the connection between genes and physical ...

Aliso Viejo-based Ambrey Genetics Corp., Orange County’s third-largest medical diagnostics and testing company, has entered ...

Tempus AI said it agreed to pay $375 million in cash and $225 million in shares to acquire genetic testing company Ambry Genetics. Ambry conducts hereditary cancer screening and currently serves as ...

Tempus announced that it has entered into an agreement to acquire Ambry Genetics, a leader in genetic testing. Under the terms of the ...

DNA synthesis platform developer joins de novo designer in latest of three partnerships recently launched or advanced.